S
49.55
-0.22 (-0.44%)
| Penutupan Terdahulu | 49.77 |
| Buka | 49.64 |
| Jumlah Dagangan | 1,893,391 |
| Purata Dagangan (3B) | 2,098,131 |
| Modal Pasaran | 2,661,331,712 |
| Harga / Pendapatan (P/E Ke hadapan) | 10.47 |
| Harga / Jualan (P/S) | 24.93 |
| Harga / Buku (P/B) | 5.51 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 4 Nov 2025 |
| EPS Cair (TTM) | -4.74 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.73% |
| Nisbah Semasa (MRQ) | 19.64 |
| Aliran Tunai Operasi (OCF TTM) | -89.32 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -33.98 M |
| Pulangan Atas Aset (ROA TTM) | -52.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -105.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Soleno Therapeutics, Inc. | Menurun | Menaik |
AISkor Stockmoo
0.8
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.0 |
| Purata | 0.75 |
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.83% |
| % Dimiliki oleh Institusi | 109.24% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 106.00 (Wells Fargo, 113.93%) | Beli |
| Median | 90.50 (82.64%) | |
| Rendah | 75.00 (Wolfe Research, 51.36%) | Beli |
| Purata | 90.50 (82.64%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 47.71 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wolfe Research | 18 Nov 2025 | 75.00 (51.36%) | Beli | 48.54 |
| Wells Fargo | 05 Nov 2025 | 106.00 (113.93%) | Beli | 46.87 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |